Scarica l'app Stockscreener
8.27
1.65%
0.14
Precedente Chiudi:
$8.13
Aprire:
$8.15
Volume 24 ore:
553.12K
Relative Volume:
0.37
Capitalizzazione di mercato:
$717.38M
Reddito:
-
Utile/perdita netta:
$-168.09M
Rapporto P/E:
-3.8111
EPS:
-2.17
Flusso di cassa netto:
$-138.01M
1 W Prestazione:
+4.61%
1M Prestazione:
+29.94%
6M Prestazione:
+12.13%
1 anno Prestazione:
-58.01%
Intervallo 1D:
$8.15
$8.48
Intervallo di 1 settimana:
$7.8561
$8.5199
Portata 52W:
$5.41
$21.40
Kura Oncology Inc Stock (KURA) Company Profile
Nome
Kura Oncology Inc
Settore
Industria
Telefono
(858) 500-8800
Indirizzo
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Confronta KURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
8.265 | 705.66M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.04 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.10 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
568.53 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
748.70 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.05 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-14 | Downgrade | Stifel | Buy → Hold |
| 2023-12-22 | Iniziato | Mizuho | Buy |
| 2023-08-11 | Iniziato | BofA Securities | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Perform |
| 2023-05-17 | Iniziato | BTIG Research | Buy |
| 2023-01-31 | Iniziato | Stifel | Buy |
| 2022-07-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-02-15 | Iniziato | Jefferies | Buy |
| 2021-05-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-11-05 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Iniziato | Credit Suisse | Outperform |
| 2020-05-05 | Iniziato | Barclays | Overweight |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2018-11-09 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-01 | Iniziato | H.C. Wainwright | Buy |
| 2016-10-13 | Ripresa | Leerink Partners | Outperform |
| 2016-01-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-30 | Iniziato | Oppenheimer | Outperform |
| 2015-12-16 | Iniziato | Citigroup | Buy |
Mostra tutto
Kura Oncology Inc Borsa (KURA) Ultime notizie
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Kura Oncology Grants Stock Options to New Employees Under Inducement Plan - AInvest
82,950 Shares: Kura Oncology Awards Stock Options to New Cancer Drug Development Team - Stock Titan
Can machine learning forecast Kura Oncology Inc. recoveryWeekly Trend Summary & Safe Entry Point Alerts - Newser
Is Kura Oncology Inc. in a long term uptrend2025 Volume Leaders & Weekly Top Stock Performers List - khodrobank.com
Short interest data insights for Kura Oncology Inc.Weekly Trading Summary & Community Verified Trade Signals - Newser
Heatmap analysis for Kura Oncology Inc. and competitors2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - Newser
Comparing Kura Oncology Inc. in custom built stock radarsInsider Buying & Comprehensive Market Scan Insights - Newser
Is Kura Oncology Inc. gaining market share2025 Top Decliners & Low Risk High Win Rate Stock Picks - khodrobank.com
Is this a good reentry point in Kura Oncology Inc.CEO Change & Low Risk High Win Rate Picks - Newser
Guggenheim initiates coverage on Kura Oncology stock with Neutral rating By Investing.com - Investing.com Canada
Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth - Benzinga
Should you wait for a breakout in Kura Oncology Inc.July 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Is it time to cut losses on Kura Oncology Inc.Weekly Investment Recap & Free AI Powered Buy and Sell Recommendations - Newser
Backtesting results for Kura Oncology Inc. trading strategiesJobs Report & Long Hold Capital Preservation Plans - Newser
Why is Kura Oncology Inc. stock going upBuy Signal & Expert-Curated Trade Recommendations - khodrobank.com
How to use a screener to detect Kura Oncology Inc. breakoutsOil Prices & AI Forecast Swing Trade Picks - Newser
What data driven models say about Kura Oncology Inc.’s future - Newser
Using RSI to spot recovery in Kura Oncology Inc.July 2025 Macro Moves & Free Technical Pattern Based Buy Signals - Newser
Will Kura Oncology Inc. outperform tech stocksTreasury Yields & Verified Swing Trading Watchlists - khodrobank.com
Is Kura Oncology Inc. stock poised for growthJuly 2025 Selloffs & Free High Return Stock Watch Alerts - Newser
Can Kura Oncology Inc. reach resistance levels soonJuly 2025 Levels & Real-Time Volume Spike Alerts - khodrobank.com
Market reaction to Kura Oncology Inc.’s recent news2025 Price Action Summary & Breakout Confirmation Alerts - Newser
What are Kura Oncology Inc.’s technical support levels2025 Valuation Update & Breakout Confirmation Alerts - khodrobank.com
Kura Oncology to Host Events Showcasing Preclinical and Clinical Data on FTI Agents and Targeted Therapies - Quiver Quantitative
Real time scanner hits for Kura Oncology Inc. explainedWeekly Trade Recap & Daily Risk Controlled Trade Plans - Newser
Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program - The Manila Times
First Clinical Data: Kura's Next-Gen Cancer Drug KO-2806 Shows Promise in Multiple Tumor Types - Stock Titan
Kura Oncology Inc. stock trend outlook and recovery pathJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
Aug Spikes: Can Kura Oncology Inc. benefit from deglobalizationJuly 2025 Update & Stepwise Trade Signal Implementation - khodrobank.com
Real time alert setup for Kura Oncology Inc. performanceJuly 2025 Weekly Recap & High Conviction Buy Zone Alerts - Newser
Is Kura Oncology Inc. stock risky to hold nowBreakout Watch & Free High Accuracy Swing Entry Alerts - khodrobank.com
Can Kura Oncology Inc. disrupt its industryInsider Selling & Weekly Watchlist of Top Performers - khodrobank.com
Top chart patterns to watch in Kura Oncology Inc.Weekly Profit Recap & Free Long-Term Investment Growth Plans - Newser
Tools to assess Kura Oncology Inc.’s risk profileMarket Volume Summary & Free AI Powered Buy and Sell Recommendations - Newser
Kura Oncology Inc. stock daily chart insightsJuly 2025 Selloffs & Consistent Income Trade Ideas - Newser
Has Kura Oncology Inc. found a price floor2025 Earnings Impact & Short-Term Trading Opportunity Alerts - Newser
Will Kura Oncology Inc. benefit from green energy policiesPortfolio Gains Report & Weekly High Return Stock Forecasts - khodrobank.com
What earnings revisions data tells us about Kura Oncology Inc.Weekly Trend Summary & Risk Controlled Daily Trade Plans - Newser
What the charts say about Kura Oncology Inc. todayMarket Growth Review & Free AI Powered Buy and Sell Recommendations - Newser
What’s the outlook for Kura Oncology Inc.’s sectorJuly 2025 Chart Watch & Real-Time Volume Triggers - khodrobank.com
Is Kura Oncology Inc. forming bullish engulfing patternsFed Meeting & AI Driven Price Forecasts - khodrobank.com
How high can Kura Oncology Inc. stock goGDP Growth & Reliable Intraday Trade Plans - Newser
Volume spikes in Kura Oncology Inc. stock – what they meanWatch List & Accurate Technical Buy Alerts - Newser
Kura Oncology Inc Azioni (KURA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Kura Oncology Inc Azioni (KURA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| WILSON TROY EDWARD | President and CEO |
Aug 13 '25 |
Buy |
6.64 |
13,494 |
89,623 |
50,968 |
| Bair Teresa Brophy | Chief Legal Officer |
May 19 '25 |
Sale |
5.96 |
1,559 |
9,292 |
107,948 |
| FORD KATHLEEN | Chief Operating Officer |
May 19 '25 |
Sale |
6.28 |
1,558 |
9,777 |
21,367 |
0.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):